Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)

Summary

The purpose of this study is to evaluate the safety and efficacy of Incobotulinum Toxin A (Xeomin®) injections into the parotid and submandibular glands in patients with Parkinson's Disease/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) with troublesome sialorrhea.

Timeline

Start

2012-03

Primary completion

2013-07

Completion

2013-07

Outcome

Outcome not reported

Stopped (Enrollment): “Could not recruit ALS participants, hence ALS arm discontinued”

Drugs

Indications